212 related articles for article (PubMed ID: 25455639)
1. Selected hybrid natural products as tubulin modulators.
Dasari B; Jimmidi R; Arya P
Eur J Med Chem; 2015 Apr; 94():497-508. PubMed ID: 25455639
[TBL] [Abstract][Full Text] [Related]
2. Diversity through semisynthesis: the chemistry and biological activity of semisynthetic epothilone derivatives.
Altmann KH; Gaugaz FZ; Schiess R
Mol Divers; 2011 May; 15(2):383-99. PubMed ID: 21197573
[TBL] [Abstract][Full Text] [Related]
3. Complex synthesis yields breast-cancer therapy.
Ledford H
Nature; 2010 Dec; 468(7324):608-9. PubMed ID: 21124423
[No Abstract] [Full Text] [Related]
4. Synthesis & antitumor activity of epothilones B and D and their analogs.
Cheng H; Huang G
Future Med Chem; 2018 Jun; 10(12):1483-1496. PubMed ID: 29788770
[TBL] [Abstract][Full Text] [Related]
5. Natural products as leads for anticancer drug discovery: discovery of new chemotypes of microtubule stabilizers through reengineering of the epothilone scaffold.
Altmann KH; Cachoux F; Feyen F; Gertsch J; Kuzniewski CN; Wartmann M
Chimia (Aarau); 2010; 64(1-2):8-13. PubMed ID: 21137676
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanism of action of microtubule-stabilizing anticancer agents.
Prota AE; Bargsten K; Zurwerra D; Field JJ; Díaz JF; Altmann KH; Steinmetz MO
Science; 2013 Feb; 339(6119):587-90. PubMed ID: 23287720
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of isotopically labeled epothilones.
Ganesh T; Brodie PJ; Banerjee A; Bane S; Kingston DG
J Labelled Comp Radiopharm; 2014 Feb; 57(2):78-81. PubMed ID: 24307484
[TBL] [Abstract][Full Text] [Related]
8. Epothilones as lead structures for new anticancer drugs--pharmacology, fermentation, and structure-activity-relationships.
Altmann KH; Memmert K
Prog Drug Res; 2008; 66():273, 275-334. PubMed ID: 18416309
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and Activity of Epothilone D.
Cheng H; Huang G
Curr Drug Targets; 2018; 19(15):1866-1870. PubMed ID: 30073925
[TBL] [Abstract][Full Text] [Related]
10. On the potential of natural products in the discovery of pharma leads: a case for reassessment.
Danishefsky S
Nat Prod Rep; 2010 Aug; 27(8):1114-6. PubMed ID: 20383353
[TBL] [Abstract][Full Text] [Related]
11. Epothilone analogues with benzimidazole and quinoline side chains: chemical synthesis, antiproliferative activity, and interactions with tubulin.
Dietrich SA; Lindauer R; Stierlin C; Gertsch J; Matesanz R; Notararigo S; Díaz JF; Altmann KH
Chemistry; 2009 Oct; 15(39):10144-57. PubMed ID: 19697384
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and SAR of C12-C13-oxazoline derivatives of epothilone A.
Pfeiffer B; Hauenstein K; Merz P; Gertsch J; Altmann KH
Bioorg Med Chem Lett; 2009 Jul; 19(14):3760-3. PubMed ID: 19433359
[TBL] [Abstract][Full Text] [Related]
13. The binding mode of side chain- and C3-modified epothilones to tubulin.
Erdélyi M; Navarro-Vázquez A; Pfeiffer B; Kuzniewski CN; Felser A; Widmer T; Gertsch J; Pera B; Díaz JF; Altmann KH; Carlomagno T
ChemMedChem; 2010 Jun; 5(6):911-20. PubMed ID: 20432490
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological activity of new functionalized epothilones for prodrug design and tumor targeting.
Dietrich SA; Riediker L; Gertsch J; Altmann KH
Chimia (Aarau); 2010; 64(3):136-9. PubMed ID: 21140905
[TBL] [Abstract][Full Text] [Related]
15. Epothilones as lead structures for the synthesis-based discovery of new chemotypes for microtubule stabilization.
Feyen F; Cachoux F; Gertsch J; Wartmann M; Altmann KH
Acc Chem Res; 2008 Jan; 41(1):21-31. PubMed ID: 18159935
[TBL] [Abstract][Full Text] [Related]
16. Sagopilone (ZK-EPO): from a natural product to a fully synthetic clinical development candidate.
Klar U; Hoffmann J; Giurescu M
Expert Opin Investig Drugs; 2008 Nov; 17(11):1735-48. PubMed ID: 18922109
[TBL] [Abstract][Full Text] [Related]
17. A landmark in drug discovery based on complex natural product synthesis.
Kawano S; Ito K; Yahata K; Kira K; Abe T; Akagi T; Asano M; Iso K; Sato Y; Matsuura F; Ohashi I; Matsumoto Y; Isomura M; Sasaki T; Fukuyama T; Miyashita Y; Kaburagi Y; Yokoi A; Asano O; Owa T; Kishi Y
Sci Rep; 2019 Jun; 9(1):8656. PubMed ID: 31209263
[TBL] [Abstract][Full Text] [Related]
18. High-resolution X-ray structure of three microtubule-stabilizing agents in complex with tubulin provide a rationale for drug design.
Xiao Q; Xue T; Shuai W; Wu C; Zhang Z; Zhang T; Zeng S; Sun B; Wang Y
Biochem Biophys Res Commun; 2021 Jan; 534():330-336. PubMed ID: 33272565
[TBL] [Abstract][Full Text] [Related]
19. Total synthesis of halichondrin A, the missing member in the halichondrin class of natural products.
Ueda A; Yamamoto A; Kato D; Kishi Y
J Am Chem Soc; 2014 Apr; 136(13):5171-6. PubMed ID: 24606005
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of natural product microtubule stabilizers on microtubule assembly: single agent and combination studies with taxol, epothilone B, and discodermolide.
Gertsch J; Meier S; Müller M; Altmann KH
Chembiochem; 2009 Jan; 10(1):166-75. PubMed ID: 19058273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
